| NOTE 3 - CASH AND CASH EQUIVALENTS |
NOTE 3 – CASH AND CASH EQUIVALENTS
As of September 30, 2021, and March 31, 2021, cash and cash equivalents consisted of the following:
|
|
September 30,
2021
|
|
|
March 31,
2021
|
|
|
|
|
|
|
|
|
Current accounts with brokers |
|
$ |
190,385 |
|
|
$ |
94,494 |
|
Securities purchased under reverse repurchase agreements |
|
|
164,240 |
|
|
|
248,946 |
|
Accounts with stock exchanges |
|
|
149,361 |
|
|
|
98,521 |
|
Current accounts with commercial banks |
|
|
90,886 |
|
|
|
75,903 |
|
Current accounts in clearing organizations |
|
|
50,312 |
|
|
|
83,194 |
|
Current account with National Bank (Kazakhstan) |
|
|
37,628 |
|
|
|
36,726 |
|
Current account with National Settlement Depository (Russia) |
|
|
26,496 |
|
|
|
28,215 |
|
Petty cash in bank vault and on hand |
|
|
22,970 |
|
|
|
25,830 |
|
Current account with Central Bank (Russia) |
|
|
7,975 |
|
|
|
6,930 |
|
Current account with Central Depository (Kazakhstan) |
|
|
172 |
|
|
|
69 |
|
Total cash and cash equivalents |
|
$ |
740,425 |
|
|
$ |
698,828 |
|
As of September 30, 2021, and March 31, 2021, with the exception of funds deposited with banks in the United States which may qualify for FDIC insurance up to $250,000, cash and cash equivalents were not insured.
As of September 30, 2021, and March 31, 2021, the cash and cash equivalents balance included collateralized securities received under reverse repurchase agreements on the terms presented below:
|
|
September 30, 2021 |
|
|
|
Interest rates and remaining contractual maturity of the agreements |
|
|
|
Average interest rate |
|
|
Up to 30 days |
|
|
30-90 days |
|
|
Total |
|
Securities purchased under reverse repurchase agreements |
|
|
|
|
|
|
|
|
|
|
|
|
Corporate equity |
|
|
0.39 |
% |
|
|
141,873 |
|
|
|
- |
|
|
|
141,873 |
|
Non-US sovereign debt |
|
|
1.20 |
% |
|
|
11,582 |
|
|
|
10 |
|
|
|
11,592 |
|
Corporate debt |
|
|
3.16 |
% |
|
|
10,775 |
|
|
|
- |
|
|
|
10,775 |
|
Total securities sold under repurchase agreements |
|
|
|
|
|
$ |
164,230 |
|
|
$ |
10 |
|
|
$ |
164,240 |
|
|
|
March 31, 2021 |
|
|
|
Interest rates and remaining contractual maturity of the agreements |
|
|
|
Average interest rate |
|
|
Up to 30 days |
|
|
30-90 days |
|
|
Total |
|
Securities purchased under reverse repurchase agreements |
|
|
|
|
|
|
|
|
|
|
|
|
Non-US sovereign debt |
|
|
1.07 |
% |
|
$ |
101,258 |
|
|
$ |
- |
|
|
|
101,258 |
|
Corporate debt |
|
|
4.42 |
% |
|
|
94,562 |
|
|
|
- |
|
|
|
94,562 |
|
Corporate equity |
|
|
2.76 |
% |
|
|
51,564 |
|
|
|
- |
|
|
|
51,564 |
|
US sovereign debt |
|
|
0.50 |
% |
|
|
1,562 |
|
|
|
- |
|
|
|
1,562 |
|
Total securities sold under repurchase agreements |
|
|
|
|
|
$ |
248,946 |
|
|
$ |
- |
|
|
$ |
248,946 |
|
The securities received by the Company as collateral under reverse repurchase agreements are liquid trading securities with market quotes and significant trading volume. The fair value of collateral received by the Company under reverse repurchase agreements as of September 30, 2021, and March 31, 2021, was $181,330 and $272,586, respectively.
|